Gilead Sciences, Inc. (GILD)

125.19 +1.03 (+0.83%) USD  |  NASDAQ  |  Dec 23, 16:00
125.22 +0.02 (+0.02%) After-Hours: 20:00
More

Gilead Sciences SG&A Expense (TTM): 5.886B for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for GILD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Amgen, Inc. 6.976B
Johnson & Johnson 23.38B
Eli Lilly & Co. 10.39B
Merck & Co., Inc. 10.70B
Regeneron Pharmaceuticals, Inc. 2.717B